Like pharmaceutical companies globally - which used to enjoy a preferential exchange rate in Venezuela - Indian producers have been left badly stung by the collapse of the bolivar currency
Farmer suicides have nearly doubled in the drought-hit Marathwada region of Maharashtra.
The USTR has placed India on its "priority watch" list for two years in a row, saying the country's patent laws unfairly favour local drug makers.
It is one of 42 drug-making factories in India that the FDA has banned in recent years
Heineken could call a shareholder meeting to vote on his ouster from a company his father built into a family empire
The next hearing on Pfizer's plea is slated for March 21
A notice issued by the Indian Health Ministry at the weekend said that a government-appointed committee of experts had found that the banned combinations were "likely to involve risk to human beings, whereas safer alternatives to the said drug are available."
Dinesh Thakur is famous for exposing Ranbaxy safety problems
Mallya will now be the Founder Emeritus of USL
Sahara has ploughed at least Rs 1,500 crore from two of its credit cooperatives into the Aamby Valley resort project
European Union steel prices hit their lowest since 2004
Government is expected to rely more on divestment proceeds to keep the fiscal deficit in check
Suspicions have swirled for years that many of Sahara's millions of investors are fictitious names
Sahara and its founder Subrata Roy have been under scrutiny for years over its financial products, including for possible money laundering.
Credit Suisse analysts cut their rating on Sun Pharma stock to 'neutral' from 'outperform
US firm Mylan NV received a stern warning from the FDA in August for faulty manufacturing practices at three of its India drugmaking plants.
IndiGo was set up in 2006 by businessman Rahul Bhatia and Rakesh Gangwal, a former CEO for US Airways Group.
Coffee Day Enterprises Ltd is backed by KKR & Co.
India rejects patent on Pfizer's arthritis drug
Cipla has agreed to buy two generics businesses in the United States in an all-cash deal worth $550 million.
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances